Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.328 | 1.712 | 0.99979 | 1.00000 | |
RegionR2 | 5.046 | 1.712 | 0.02040 | 0.15506 | |
RegionR3 | 0.473 | 1.712 | 0.48039 | 0.98275 | |
RegionR4 | 0.23 | 1.712 | 0.69595 | 0.98615 | |
RegionR5 | 0.204 | 1.712 | 0.54062 | 0.90362 | |
RegionR6 | -2.434 | 1.712 | 0.99981 | 1.00000 | |
RegionR7 | -2.014 | 1.712 | 0.99985 | 1.00000 | |
RegionR8 | -1.833 | 1.712 | 0.99984 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 5.21 | 1.712 | 0.46367 | 1.00000 | |
RegenerationR2 | -0.356 | 1.712 | 0.58392 | 0.90846 | |
RegenerationR3 | -1.167 | 1.712 | 0.41941 | 0.81444 | |
RegenerationR4 | -0.554 | 1.712 | 0.92969 | 1.00000 | |
RegenerationR5 | -2.494 | 1.712 | 0.07392 | 0.42590 | |
RegenerationR6 | 2.386 | 1.712 | 0.20964 | 0.55274 | |
RegenerationBL | -0.276 | 1.712 | 0.99999 | 1.00000 | |
RegenerationTP | 0.598 | 1.712 | 0.70608 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
2. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
4.783 | 0.799 | - | 0.991 | 0.995 | 0.998 | 1.000 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
3. | MligTC455_18614 | 342 | 7.13 | Mlig455_021102 | Neo: - Age: logFC(26M/2M)=1.052 Region-specific R2: 6.427 Region-enriched R2: 5.869/0.00003 |
4.67 | 0.881 | - | 0.941 | 0.984 | 0.983 | 0.881 | Mlig455_021102 {REF} {Length: 1417} {RNA1509_43477} {RNA1310_26398} {RNA815_11119} | |
4. | MligTC455_53682 | 393 | 8.18 | Mlig455_064952, Mlig455_066834 | Neo: - Age: Down-Up-Up Region-specific R2: 5.926 Region-enriched R2: 4.442/0.00896 |
4.55 | 0.886 | - | 0.919 | 0.920 | 0.855 | 0.970 | Mlig455_064952 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} Mlig455_066834 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} |
|
5. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 4.45 | 0.911 | - | 0.842 | 0.955 | 0.753 | 0.989 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
6. | MligTC455_47712 | 80 | 1.66 | Mlig455_044833 | Neo: - Age: - |
4.45 | 0.917 | - | 0.976 | 0.754 | 0.812 | 0.991 | Mlig455_044833 {REF} {Length: 564} {RNA1509_55855} {RNA1310_87612} {RNA815_50831} | |
7. | MligTC455_42994 | 1521 | 31.7 | Mlig455_035840 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.356 Region-enriched R2: 1.854/0.00052 |
4.45 | 0.843 | - | 0.957 | 0.910 | 0.760 | 0.980 | Mlig455_035840 {REF} {Length: 1436} {RNA1509_29485, RNA1509_42231} {RNA1310_26640, RNA1509_29485, RNA1509_42231} {RNA1509_29485, RNA1509_42231, RNA815_37260} | |
8. | MligTC455_53239 | 733 | 15.27 | Mlig455_025537 | Neo: - Age: - Region-specific R2: 4.434 Region-enriched R2: 3.108/0.00000 |
4.401 | 0.776 | - | 0.881 | 0.848 | 0.932 | 0.964 | Mlig455_025537 {REF} {Length: 964} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=70.9, Expect=5e-15]} {Celegans: WBGene00010290, F58H1.7, [Score=63.9, Expect=8e-13]} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [RH, Score=168, Expect=2e-53]} {RNA1509_58542} {RNA1310_40950} {RNA815_19778.1} | |
9. | MligTC455_46394 | 8810 | 183.54 | Mlig455_054818, Mlig455_054826 | Neo: - Age: - Region-specific R2: 1.771 Region-enriched R2: 1.255/0.00038 |
PKD2 | 4.392 | 0.870 | - | 0.857 | 0.982 | 0.708 | 0.975 | Mlig455_054818 {REF} {Length: 2992} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=750, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=747, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=380, Expect=6e-120]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=733, Expect=0.0]} {RNA1509_1615} {RNA1310_21296.2, RNA1509_1615} {RNA1509_1615, RNA815_3158.1} Mlig455_054826 {REF} {Length: 3118} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.4]; EF hand [PF00036.34, score=32.6]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=754, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=751, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=2e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
10. | MligTC455_36985 | 363 | 7.57 | Mlig455_046905 | Neo: - |
SCNN1A | 4.391 | 0.818 | - | 0.721 | 0.964 | 0.894 | 0.994 | Mlig455_046905 {REF} {Length: 2490} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=171.1]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=68.6, Expect=2e-11]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=67.0, Expect=3e-11]} {Celegans: WBGene00006748, unc-8, Degenerin unc-8, [Score=58.2, Expect=1e-08]} {Smed: dd_Smed_v6_29341_0_1, dd_Smed_v6_29341_0_1, [Score=100, Expect=2e-22]} {RNA1509_33610} {RNA1310_13314.1, RNA1509_33610} {RNA1509_33610, RNA815_4277} |
11. | MligTC455_42579 | 1841 | 38.34 | Mlig455_061617 | Neo: - Age: - Region-enriched R7: 1.560/0.01513 Regeneration-downregulated BL: -2.445 Regeneration-depleted BL: -2.445 |
CAV2 | 4.38 | 0.763 | - | 0.877 | 0.991 | 0.777 | 0.972 | Mlig455_061617 {REF} {Length: 4295} {Pfam: Caveolin [PF01146.19, score=121.3]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=87.4, Expect=2e-22]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=90.1, Expect=1e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.2, Expect=1e-16]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [Score=144, Expect=2e-45]} {RNA1509_24227} {RNA1310_41576, RNA1509_24227} {RNA1509_24227, RNA815_20166} |
12. | MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | 4.355 | 0.797 | 0.904 | 0.911 | 0.765 | - | 0.978 | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
13. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
4.311 | 0.769 | 0.953 | 0.892 | 0.714 | - | 0.983 | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
14. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 4.244 | 0.906 | - | 0.910 | 0.757 | 0.705 | 0.966 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
15. | MligTC455_19339 | 1746 | 36.37 | Mlig455_055775 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.338 Region-specific R2: 3.573 Region-enriched R2: 2.166/0.00065 |
4.239 | 0.709 | - | 0.818 | 0.869 | 0.970 | 0.873 | Mlig455_055775 {REF} {Length: 1701} {TRANSSPLICED} {RNA1509_28058, RNA1509_53885} {RNA1310_50737, RNA1509_28058, RNA1509_53885} {RNA1509_28058, RNA1509_53885, RNA815_26880} | |
16. | MligTC455_27938 | 137 | 2.85 | Mlig455_033961 | Neo: - Age: - |
3.865 | - | - | 0.898 | 0.995 | 0.984 | 0.988 | Mlig455_033961 {REF} {Length: 3296} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_28736.1} {RNA815_45605} | |
17. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
3.835 | - | - | 0.989 | 0.953 | 0.896 | 0.997 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
18. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
3.766 | 0.901 | - | 0.949 | 0.929 | - | 0.987 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
19. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 3.766 | 0.812 | - | 0.963 | 0.995 | - | 0.996 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
20. | MligTC455_53681 | 335 | 6.99 | Mlig455_064921 | Neo: - Age: - Region-enriched R2: 6.469/0.00000 |
3.763 | 0.899 | - | 0.966 | 0.994 | 0.904 | - | Mlig455_064921 {REF} {Length: 1504} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_33258} {RNA815_17150} | |
21. | MligTC455_48561 | 779 | 16.24 | Mlig455_034702, Mlig455_034755 | Neo: - Age: - |
FABP4 | 3.758 | - | - | 0.953 | 0.972 | 0.913 | 0.920 | Mlig455_034702 {REF} {Length: 723} {Human: ENSG00000170323, FABP4, fatty acid binding protein 4, [Score=43.9, Expect=8e-06]} {RNA1509_39777} {RNA1310_54956} {RNA815_27929.1} Mlig455_034755 {REF} {Length: 924} {Human: ENSG00000170323, FABP4, fatty acid binding protein 4, [Score=43.9, Expect=8e-06]} {RNA1509_39777} {RNA1310_54956, RNA1509_39777} {RNA1509_39777, RNA815_27929.1} |
22. | MligTC455_49926 | 50 | 1.04 | Mlig455_062317 | Neo: - Age: - |
VSX1 | 3.756 | - | - | 0.859 | 0.947 | 0.962 | 0.988 | Mlig455_062317 {REF} {Length: 1610} {Pfam: Homeodomain [PF00046.31, score=79.8]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=202, Expect=4e-61]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=201, Expect=1e-60]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=201, Expect=8e-61]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=198, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=208, Expect=6e-61]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=210, Expect=1e-64]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=212, Expect=1e-65]} {RNA1310_39008} {RNA815_19602} |
23. | MligTC455_45495 | 988 | 20.58 | Mlig455_010003 | Neo: - Age: logFC(26M/2M)=0.384 Region-enriched R2: 2.517/0.00003 |
CAV2 | 3.753 | 0.882 | - | 0.908 | 0.972 | - | 0.991 | Mlig455_010003 {REF} {Length: 748} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1} {RNA815_31873} |
24. | MligTC455_18682 | 1190 | 24.79 | Mlig455_037756 | Neo: - Age: Up-Down-Down Region-specific R2: 4.877 Region-enriched R2: 4.609/0.00000 |
3.751 | 0.876 | - | 0.948 | 0.930 | - | 0.997 | Mlig455_037756 {REF} {Length: 1188} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
25. | MligTC455_46605 | 388 | 8.08 | Mlig455_032055 | Neo: - Age: - Region-specific R2: 4.152 |
3.74 | 0.914 | - | 0.884 | 0.977 | - | 0.965 | Mlig455_032055 {REF} {Length: 1416} {RNA1310_44339} {RNA815_20624} | |
26. | MligTC455_19266 | 1038 | 21.61 | Mlig455_004528, Mlig455_028530 | Neo: - Age: - Region-specific R2: 2.706 Region-enriched R2: 1.766/0.00005 |
NCALD | 3.704 | 0.890 | - | 0.938 | 0.967 | - | 0.909 | Mlig455_004528 {REF} {Length: 3958} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_14564} {RNA1310_18405, RNA1509_14564} {RNA1509_14564, RNA815_10180.1} Mlig455_028530 {REF} {Length: 3453} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_13995, RNA1509_14564, RNA1509_30926} {RNA1310_18405, RNA1509_13995, RNA1509_30926} {RNA1509_13995, RNA1509_30926, RNA815_10180.1} |
27. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
3.7 | 0.804 | - | 0.948 | 0.950 | - | 0.998 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
28. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 3.693 | 0.935 | - | 0.934 | 0.834 | - | 0.990 | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
29. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
3.668 | 0.711 | - | 0.995 | 0.966 | - | 0.996 | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
30. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
3.662 | - | - | 0.841 | 0.976 | 0.859 | 0.986 | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
31. | MligTC455_19114 | 79 | 1.64 | Mlig455_045107 | Neo: - |
3.66 | - | - | 0.866 | 0.910 | 0.891 | 0.993 | Mlig455_045107 {REF} {Length: 1513} {Pfam: F5/8 type C domain [PF00754.27, score=20.0]} {RNA1509_57504} {RNA1310_27303.2} {RNA815_32964} | |
32. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 3.658 | 0.719 | - | 0.981 | 0.992 | - | 0.966 | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
33. | MligTC455_36842 | 340 | 7.08 | Mlig455_056552 | Neo: - Age: - Region-enriched R2: 2.409/0.00668 |
SYT11 | 3.657 | - | 0.981 | 0.917 | 0.858 | - | 0.901 | Mlig455_056552 {REF} {Length: 3533} {Pfam: C2 domain [PF00168.32, score=153.6]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=310, Expect=7e-102]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=309, Expect=8e-102]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=355, Expect=3e-119]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=237, Expect=1e-74]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [Score=372, Expect=4e-127]} {RNA1509_16916, RNA1509_47189} {RNA1310_9964.1, RNA1509_16916, RNA1509_47189} {RNA1509_16916, RNA1509_47189, RNA815_17687} |
34. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
3.656 | - | - | 0.947 | 0.974 | 0.747 | 0.988 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
35. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
3.646 | 0.720 | - | 0.983 | 0.945 | - | 0.998 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
36. | MligTC455_34499 | 65 | 1.36 | Mlig455_025160, Mlig455_063937 | Neo: - Age: - |
3.642 | 0.701 | - | 0.953 | 0.993 | - | 0.995 | Mlig455_025160 {REF} {Length: 942} {RNA1310_54940} {RNA815_33690.1} Mlig455_063937 {REF} {Length: 995} {RNA1310_54940} {RNA815_33690.1} |
|
37. | MligTC455_20015 | 52 | 1.09 | Mlig455_026589 | Neo: - Age: - |
3.64 | - | - | 0.962 | 0.963 | 0.741 | 0.974 | Mlig455_026589 {REF} {Length: 611} {RNA1310_66647} {RNA815_33955} | |
38. | MligTC455_03841 | 920 | 19.16 | Mlig455_018790, Mlig455_048140 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.474 Region-enriched R2: 5.915/0.00081 |
NKX2-1, NKX2-4 | 3.634 | 0.961 | - | 0.761 | 0.991 | - | 0.921 | Mlig455_018790 {REF} {Length: 2203} {Pfam: Homeodomain [PF00046.31, score=72.7]} {Human: ENSG00000136352, NKX2-1, NK2 homeobox 1, [RH, Score=145, Expect=2e-39]; ENSG00000125816, NKX2-4, NK2 homeobox 4, [RH, Score=145, Expect=2e-39]} {Mouse: ENSMUSG00000001496, Nkx2-1, NK2 homeobox 1, [RH, Score=145, Expect=2e-39]} {Dmel: FBgn0028993, scro, scarecrow, [RH, Score=166, Expect=8e-47]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [RH, Score=134, Expect=2e-36]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [RH, Score=191, Expect=1e-57]} {RNA1509_12761} {RNA1310_13401} {RNA815_21584} Mlig455_048140 {REF} {Length: 2218} {Pfam: Homeodomain [PF00046.31, score=72.5]} {Human: ENSG00000125816, NKX2-4, NK2 homeobox 4, [RH, Score=145, Expect=3e-39]; ENSG00000136352, NKX2-1, NK2 homeobox 1, [RH, Score=145, Expect=7e-39]} {Mouse: ENSMUSG00000001496, Nkx2-1, NK2 homeobox 1, [RH, Score=144, Expect=6e-39]} {Dmel: FBgn0028993, scro, scarecrow, [RH, Score=166, Expect=2e-46]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [RH, Score=136, Expect=1e-36]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [RH, Score=193, Expect=1e-57]} {RNA1509_12761} {RNA1310_13401, RNA1509_12761} {RNA1509_12761, RNA815_21584} |
39. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
3.634 | 0.910 | - | 0.898 | 0.834 | - | 0.992 | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
40. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
3.633 | 0.710 | - | 0.967 | 0.963 | - | 0.993 | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
41. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
3.63 | 0.711 | - | 0.931 | 0.988 | - | 1.000 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
42. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
3.629 | 0.714 | - | 0.979 | 0.956 | - | 0.980 | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
43. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
3.626 | - | - | 0.942 | 0.977 | 0.732 | 0.975 | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
44. | MligTC455_34115 | 6573 | 136.93 | Mlig455_017846, Mlig455_047865 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.581 Region-enriched R2: 4.896/0.00130 |
3.622 | 0.817 | - | 0.893 | 0.955 | - | 0.957 | Mlig455_017846 {REF} {Length: 1260} {RNA1509_3560, RNA1509_36840, RNA1509_42552, RNA1509_4845, RNA1509_7701} {RNA1310_63880, RNA1509_3560, RNA1509_36840, RNA1509_42552, RNA1509_4845, RNA1509_7701} {RNA1509_3560, RNA1509_36840, RNA1509_42552, RNA1509_4845, RNA1509_7701, RNA815_12890.1} Mlig455_047865 {REF} {Length: 1135} {RNA1509_4845} {RNA1310_63880} {RNA815_12890.1} |
|
45. | MligTC455_41870 | 67 | 1.39 | Mlig455_042417 | Neo: - Age: Up-Down-Up |
ANGPTL1 | 3.618 | - | - | 0.979 | 0.810 | 0.853 | 0.976 | Mlig455_042417 {REF} {Length: 1469} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=110.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=102, Expect=6e-24]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=99.8, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=104, Expect=6e-25]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=99.4, Expect=4e-23]} {Dmel: FBgn0003326, sca, scabrous, [Score=89.4, Expect=1e-19]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_28467} {RNA1310_67810} {RNA815_18070.1} |
46. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 3.616 | 0.708 | - | 0.940 | 0.971 | - | 0.997 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
47. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 3.613 | 0.711 | - | 0.937 | 0.969 | - | 0.996 | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
48. | MligTC455_37793 | 353 | 7.36 | Mlig455_066109, Mlig455_068663 | Neo: - Age: Up-Down-Down |
HMCN1 | 3.605 | 0.772 | - | 0.923 | 0.917 | - | 0.993 | Mlig455_066109 {REF} {Length: 7924} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=408.1]; Spondin-like TSP1 domain [PF19028.2, score=285.5]; Polycystin cation channel [PF08016.14, score=239.7]; PLAT/LH2 domain [PF01477.25, score=86.7]; Thrombospondin type 1 domain [PF19030.2, score=78.4]; Ion transport protein [PF00520.33, score=42.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=360, Expect=8e-99]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=363, Expect=7e-100]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=199, Expect=5e-51]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=306, Expect=4e-84]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [RH, Score=944, Expect=0.0]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} Mlig455_068663 {REF} {Length: 7866} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=423.7]; Spondin-like TSP1 domain [PF19028.2, score=299.7]; Thrombospondin type 1 domain [PF19030.2, score=92.3]; PLAT/LH2 domain [PF01477.25, score=23.1]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=338, Expect=1e-94]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=341, Expect=9e-96]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=189, Expect=2e-48]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=303, Expect=2e-84]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=282, Expect=3e-77]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} |
49. | MligTC455_41035 | 366 | 7.62 | Mlig455_000866 | Neo: - Age: logFC(26M/2M)=-0.773 Region-specific R2: 5.029 Region-enriched R2: 4.768/0.00000 |
3.591 | 0.865 | - | 0.952 | 0.790 | - | 0.984 | Mlig455_000866 {REF} {Length: 1126} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.6]} {RNA1509_27581} {RNA1310_74103, RNA1509_27581} {RNA1509_27581, RNA815_38377} | |
50. | MligTC455_16096 | 69 | 1.44 | Mlig455_059809 | Neo: - Age: - |
ANGPTL1 | 3.577 | - | 0.942 | 0.792 | 0.846 | - | 0.997 | Mlig455_059809 {REF} {Length: 1391} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=117.9]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=109, Expect=1e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=106, Expect=2e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=110, Expect=3e-27]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=105, Expect=2e-25]} {Dmel: FBgn0003326, sca, scabrous, [Score=91.3, Expect=3e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.2, Expect=1e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=77.8, Expect=5e-16]} {RNA1509_28467} {RNA1310_47262} {RNA815_18070.1} |
51. | MligTC455_42840 | 147 | 3.06 | Mlig455_003645 | Neo: - Age: - |
3.577 | - | - | 0.966 | 0.980 | 0.755 | 0.876 | Mlig455_003645 {REF} {Length: 1270} {RNA1509_48973} {RNA1310_36721} {RNA815_36286} | |
52. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 3.572 | 0.708 | - | 0.932 | 0.933 | - | 0.999 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
53. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 3.57 | 0.711 | - | 0.929 | 0.983 | - | 0.947 | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
54. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
3.564 | 0.711 | - | 0.921 | 0.940 | - | 0.992 | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
55. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
3.564 | 0.858 | - | 0.977 | 0.734 | - | 0.995 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
56. | MligTC455_27107 | 112 | 2.34 | Mlig455_063632 | Neo: - Age: Up-Down-Down |
3.562 | - | - | 0.969 | 0.928 | 0.805 | 0.860 | Mlig455_063632 {REF} {Length: 6095} {Pfam: TIR domain [PF13676.8, score=156.9]; Death domain [PF00531.24, score=29.6]; TIR domain [PF01582.22, score=27.3]} {Smed: dd_Smed_v6_12177_0_1, dd_Smed_v6_12177_0_1, [RH, Score=637, Expect=0.0]} {RNA1509_29883} {RNA1310_6245} {RNA815_1037} | |
57. | MligTC455_46395 | 870 | 18.13 | Mlig455_069471 | Neo: - Age: logFC(26M/2M)=0.458 |
PKD2 | 3.557 | 0.793 | - | 0.866 | 0.927 | - | 0.971 | Mlig455_069471 {REF} {Length: 3122} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.8]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=753, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=750, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=8e-123]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
58. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 3.557 | 0.711 | - | 0.933 | 0.925 | - | 0.988 | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
59. | MligTC455_39097 | 57 | 1.18 | Mlig455_051961 | Neo: - Age: - Region-enriched R4: 5.550/0.02060 |
3.555 | - | - | 0.967 | 0.772 | 0.824 | 0.992 | Mlig455_051961 {REF} {Length: 1972} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1509_13138} {RNA1310_34740} {RNA815_15663} | |
60. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 3.551 | 0.817 | - | 0.969 | 0.778 | - | 0.987 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
61. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 3.548 | 0.814 | - | 0.947 | 0.788 | - | 0.999 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
62. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
3.548 | 0.866 | - | 0.955 | 0.732 | - | 0.995 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
63. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 3.542 | - | - | 0.892 | 0.871 | 0.782 | 0.997 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
64. | MligTC455_48034 | 2940 | 61.24 | Mlig455_019197 | Neo: - Age: Down-Up-Down Region-specific R2: 3.626 Region-enriched R2: 3.016/0.00000 |
3.532 | 0.960 | - | 0.858 | 0.814 | - | 0.900 | Mlig455_019197 {REF} {Length: 837} {TRANSSPLICED} {RNA1509_18675, RNA1509_21674, RNA1509_29285, RNA1509_6143} {RNA1310_17472, RNA1509_18675, RNA1509_21674, RNA1509_29285, RNA1509_6143} {RNA1509_18675, RNA1509_21674, RNA1509_29285, RNA1509_6143, RNA815_19105} | |
65. | MligTC455_29050 | 162 | 3.38 | Mlig455_004578 | Neo: - Age: - |
TMEM30A | 3.525 | - | - | 0.966 | 0.703 | 0.894 | 0.962 | Mlig455_004578 {REF} {Length: 3215} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=266.2]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [Score=210, Expect=3e-64]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [Score=214, Expect=4e-66]} {Dmel: FBgn0030752, CG9947, [Score=253, Expect=1e-81]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=218, Expect=8e-68]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=258, Expect=9e-84]} {RNA1509_38539} {RNA1310_9371} {RNA815_12157} |
66. | MligTC455_19524 | 100 | 2.09 | Mlig455_010263 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.437/0.01311 |
3.525 | - | - | 0.792 | 0.928 | 0.836 | 0.969 | Mlig455_010263 {REF} {Length: 2969} {RNA1310_11925.1} {RNA815_27110} | |
67. | MligTC455_46313 | 525 | 10.93 | Mlig455_061072, Mlig455_061118 | Neo: - Age: Down-Up-Down |
3.522 | - | 0.977 | 0.898 | 0.715 | - | 0.932 | Mlig455_061072 {REF} {Length: 1336} {Pfam: Stathmin family [PF00836.21, score=30.8]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [Score=63.2, Expect=3e-14]} {RNA1509_8850} {RNA1310_39143} {RNA815_16363} Mlig455_061118 {REF} {Length: 1813} {Pfam: Stathmin family [PF00836.21, score=27.4]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [Score=63.5, Expect=2e-14]} {RNA1509_8850} {RNA1310_39143} {RNA815_16363} |
|
68. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
3.522 | 0.705 | - | 0.966 | 0.858 | - | 0.993 | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
69. | MligTC455_46067 | 548 | 11.42 | Mlig455_054518, Mlig455_055436, Mlig455_055448 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.305/0.04262 |
GRIK3, GRIK4 | 3.521 | 0.848 | - | 0.725 | 0.957 | - | 0.991 | Mlig455_054518 {REF} {Length: 4725} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=91.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.2]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=222, Expect=5e-60]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=222, Expect=6e-60]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=218, Expect=3e-58]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=216, Expect=3e-58]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=215, Expect=1e-57]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=213, Expect=9e-57]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=213, Expect=9e-57]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=224, Expect=2e-60]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=224, Expect=9e-61]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=220, Expect=2e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=216, Expect=2e-58]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=215, Expect=1e-57]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=296, Expect=6e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=312, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_14215, RNA1509_40992} {RNA1310_5620.1, RNA1509_14215, RNA1509_40992} {RNA1509_14215, RNA1509_40992, RNA815_1965} Mlig455_055436 {REF} {Length: 4732} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=90.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=219, Expect=6e-59]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=218, Expect=7e-59]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=218, Expect=7e-59]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=216, Expect=3e-58]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=216, Expect=9e-58]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=211, Expect=2e-56]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=209, Expect=1e-55]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=226, Expect=3e-61]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=221, Expect=1e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=216, Expect=2e-58]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=216, Expect=2e-58]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=216, Expect=3e-58]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=297, Expect=2e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_40992} {RNA1310_5620.1} {RNA815_1965} Mlig455_055448 {REF} {Length: 4726} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=90.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=219, Expect=9e-59]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=218, Expect=9e-59]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=218, Expect=8e-59]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=217, Expect=2e-58]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=216, Expect=7e-58]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=213, Expect=6e-57]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=209, Expect=1e-55]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=225, Expect=4e-61]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=221, Expect=1e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=217, Expect=9e-59]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=216, Expect=5e-58]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=216, Expect=3e-58]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=297, Expect=2e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_32892, RNA1509_40992} {RNA1310_5620.1, RNA1509_32892} {RNA1509_32892, RNA815_1965} |
70. | MligTC455_41339 | 61 | 1.27 | Mlig455_021120 | Neo: - Age: - |
3.515 | - | - | 0.968 | 0.730 | 0.823 | 0.994 | Mlig455_021120 {REF} {Length: 294} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_118897} {RNA815_62550} | |
71. | MligTC455_23567 | 109 | 2.27 | Mlig455_013185 | Neo: - Age: Down-Up-Down |
BCHE | 3.514 | 0.769 | - | 0.932 | 0.979 | 0.834 | - | Mlig455_013185 {REF} {Length: 4455} {Pfam: Carboxylesterase family [PF00135.30, score=432.1]; alpha/beta hydrolase fold [PF07859.15, score=35.5]} {Human: ENSG00000114200, BCHE, butyrylcholinesterase, [Score=317, Expect=9e-99]; ENSG00000087085, ACHE, acetylcholinesterase (Cartwright blood group), [Score=312, Expect=2e-96]} {Mouse: ENSMUSG00000027792, Bche, butyrylcholinesterase, [Score=324, Expect=3e-101]} {Dmel: FBgn0000024, Ace, Acetylcholine esterase, [Score=249, Expect=8e-73]} {Celegans: WBGene00000035, ace-1, Acetylcholinesterase 1, [Score=327, Expect=2e-102]} {Smed: dd_Smed_v6_15930_0_1, dd_Smed_v6_15930_0_1, [RH, Score=412, Expect=4e-134]} {RNA1509_26775} {RNA1310_8383.1} {RNA815_10983} |
72. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
3.513 | 0.787 | - | 0.964 | 0.774 | - | 0.988 | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
73. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
3.507 | - | 0.981 | 0.733 | - | 0.850 | 0.943 | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
74. | MligTC455_29045 | 127 | 2.65 | Mlig455_056054 | Neo: - Age: - Region-enriched R2: 4.858/0.00652 |
FZD5 | 3.499 | 0.719 | - | - | 0.866 | 0.918 | 0.996 | Mlig455_056054 {REF} {Length: 3655} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=389.0]; Fz domain [PF01392.24, score=85.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=554, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [Score=561, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=516, Expect=5e-176]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=368, Expect=3e-120]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [Score=522, Expect=7e-178]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
75. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 3.496 | 0.717 | - | 0.944 | 0.854 | - | 0.981 | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
76. | MligTC455_39544 | 611 | 12.73 | Mlig455_001809, Mlig455_001836, Mlig455_062227, Mlig455_062236 | Neo: - Age: - Region-specific R2: 8.576 Region-enriched R2: 8.112/0.00016 |
3.49 | 0.855 | - | 0.955 | - | 0.774 | 0.906 | Mlig455_001809 {REF} {Length: 1067} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_001836 {REF} {Length: 1065} {RNA1509_52939} {RNA1310_72581, RNA1509_52939} {RNA1509_52939, RNA815_24546} Mlig455_062227 {REF} {Length: 3520} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} Mlig455_062236 {REF} {Length: 620} {RNA1509_52939} {RNA1310_72581} {RNA815_24546} |
|
77. | MligTC455_41036 | 281 | 5.86 | Mlig455_057198 | Neo: - Age: - Region-specific R2: 5.284 Region-enriched R2: 4.243/0.00075 |
3.49 | 0.860 | - | 0.826 | 0.812 | - | 0.992 | Mlig455_057198 {REF} {Length: 538} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.9]} {RNA1509_42071} {RNA1310_74103, RNA1509_42071} {RNA1509_42071, RNA815_38377} | |
78. | MligTC455_17701 | 1279 | 26.65 | Mlig455_051483 | Neo: - Age: Down-Up-Up Region-specific R2: 5.592 Region-enriched R2: 6.602/0.00000 |
3.484 | 0.851 | - | 0.966 | 0.928 | - | 0.739 | Mlig455_051483 {REF} {Length: 1833} {RNA1509_14131} {RNA1310_69964.2, RNA1509_14131} {RNA1509_14131, RNA815_35453.1} | |
79. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
3.484 | 0.700 | - | 0.855 | 0.937 | - | 0.992 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
80. | MligTC455_32644 | 41 | 0.86 | Mlig455_043770, Mlig455_043786 | Neo: - Age: - Region-enriched R2: 6.705/0.00336 |
3.484 | 0.702 | - | 0.953 | 0.834 | - | 0.995 | Mlig455_043770 {REF} {Length: 1011} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.8, Expect=3e-11]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} Mlig455_043786 {REF} {Length: 1348} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
81. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 3.476 | 0.706 | - | 0.949 | 0.840 | - | 0.981 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
82. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
3.474 | 0.980 | - | 0.970 | 0.793 | - | 0.731 | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
83. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 3.473 | - | - | 0.841 | 0.909 | 0.763 | 0.960 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
84. | MligTC455_38288 | 5006 | 104.28 | Mlig455_045260, Mlig455_069180 | Neo: - Age: logFC(26M/2M)=0.302 Region-specific R2: 4.563 Region-enriched R2: 3.648/0.00002 |
RNF217 | 3.464 | - | - | 0.921 | 0.956 | 0.878 | 0.709 | Mlig455_045260 {REF} {Length: 2327} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=53.3]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=129, Expect=8e-31]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=124, Expect=1e-29]} {Dmel: FBgn0031857, LUBEL, Linear Ubiquitin E3 ligase, [Score=56.2, Expect=1e-07]} {Smed: dd_Smed_v6_7110_0_1, dd_Smed_v6_7110_0_1, [Score=114, Expect=1e-26]} {RNA1509_27317} {RNA1310_23955} {RNA815_6068} Mlig455_069180 {REF} {Length: 2719} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=54.2]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=130, Expect=3e-31]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=125, Expect=4e-30]} {Dmel: FBgn0031857, LUBEL, Linear Ubiquitin E3 ligase, [Score=55.8, Expect=1e-07]} {Smed: dd_Smed_v6_7110_0_1, dd_Smed_v6_7110_0_1, [Score=113, Expect=3e-26]} {RNA1509_27317} {RNA1310_23955} {RNA815_6068} |
85. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 3.459 | 0.705 | - | 0.959 | 0.798 | - | 0.997 | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
86. | MligTC455_27106 | 105 | 2.18 | Mlig455_022612 | Neo: - Age: Up-Down-Down |
3.456 | - | - | 0.962 | 0.876 | 0.777 | 0.841 | Mlig455_022612 {REF} {Length: 6144} {TRANSSPLICED} {Pfam: TIR domain [PF13676.8, score=157.1]; TIR domain [PF01582.22, score=29.6]; Death domain [PF00531.24, score=29.1]} {Smed: dd_Smed_v6_12177_0_1, dd_Smed_v6_12177_0_1, [RH, Score=638, Expect=0.0]} {RNA1509_29883, RNA1509_42445, RNA1509_47365} {RNA1310_6245, RNA1509_29883, RNA1509_42445, RNA1509_47365} {RNA1509_29883, RNA1509_42445, RNA1509_47365, RNA815_1037} | |
87. | MligTC455_53190 | 105 | 2.18 | Mlig455_013516 | Neo: - Age: - |
SCNN1B | 3.456 | 0.721 | - | 0.851 | 0.976 | - | 0.908 | Mlig455_013516 {REF} {Length: 2819} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=290.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=158, Expect=8e-41]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=149, Expect=1e-37]} {Dmel: FBgn0051105, ppk22, pickpocket 22, [RH, Score=60.1, Expect=3e-09]} {Celegans: WBGene00006748, unc-8, Degenerin unc-8, [RH, Score=166, Expect=2e-43]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [RH, Score=186, Expect=1e-51]} {RNA1509_18670} {RNA1310_20526} {RNA815_9932} |
88. | MligTC455_34952 | 124 | 2.59 | Mlig455_012890 | Neo: - Age: Up-Down-Down Region-enriched R7: 3.857/0.02491 |
ANGPTL7 | 3.445 | - | - | 0.846 | 0.853 | 0.973 | 0.773 | Mlig455_012890 {REF} {Length: 1624} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=123.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=102, Expect=1e-24]; ENSG00000120332, TNN, tenascin N, [Score=101, Expect=3e-23]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=98.2, Expect=2e-22]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=100, Expect=4e-24]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.4, Expect=4e-22]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=97.1, Expect=2e-22]} {Dmel: FBgn0034160, CG5550, [Score=107, Expect=2e-27]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=108, Expect=2e-26]} {RNA1509_54507} {RNA1310_26965} {RNA815_12335} |
89. | MligTC455_16873 | 645 | 13.43 | Mlig455_006290 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.543/0.01560 |
3.438 | 0.792 | - | - | 0.910 | 0.784 | 0.952 | Mlig455_006290 {REF} {Length: 699} {RNA1310_48111} {RNA815_24753} | |
90. | MligTC455_42645 | 144 | 3 | Mlig455_012431 | Neo: - Age: - |
KRT8 | 3.432 | 0.763 | - | 0.973 | - | 0.929 | 0.767 | Mlig455_012431 {REF} {Length: 3911} {Pfam: Intermediate filament protein [PF00038.23, score=141.4]; BRE1 E3 ubiquitin ligase [PF08647.13, score=19.8]; Protein of unknown function (DUF3450) [PF11932.10, score=18.3]} {Human: ENSG00000170421, KRT8, keratin 8, [RH, Score=109, Expect=9e-25]; ENSG00000185640, KRT79, keratin 79, [RH, Score=105, Expect=2e-23]} {Mouse: ENSMUSG00000063661, Krt73, keratin 73, [RH, Score=104, Expect=2e-23]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=138, Expect=2e-34]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=246, Expect=3e-74]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=271, Expect=9e-84]} {RNA1310_10400} {RNA815_12264} |
91. | MligTC455_50664 | 138 | 2.87 | Mlig455_035152 | Neo: - Age: - Region-enriched R2: 3.712/0.01441 |
LRRC74A | 3.429 | - | - | 0.776 | 0.790 | 0.904 | 0.959 | Mlig455_035152 {REF} {Length: 2523} {TRANSSPLICED} {Pfam: Leucine Rich repeat [PF13516.8, score=68.7]; Leucine Rich Repeat [PF00560.35, score=35.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=31.8]; Leucine rich repeat [PF13855.8, score=22.7]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=146, Expect=1e-37]; ENSG00000187905, LRRC74B, leucine rich repeat containing 74B, [Score=144, Expect=1e-37]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=147, Expect=5e-38]; ENSMUSG00000022759, Lrrc74b, leucine rich repeat containing 74B, [Score=144, Expect=1e-37]} {Dmel: FBgn0033212, LRR, Leucine-rich repeat, [Score=51.6, Expect=2e-06]} {Celegans: WBGene00009201, F28C1.3, Protein phosphatase 1 regulatory subunit 37 homolog, [Score=55.5, Expect=8e-08]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=147, Expect=6e-38]} {RNA1509_21228} {RNA1310_12842} {RNA815_17243} |
92. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 3.429 | 0.731 | - | 0.961 | 0.918 | - | 0.819 | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
93. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
3.427 | 0.744 | - | 0.983 | 0.704 | - | 0.996 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
94. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
3.426 | - | - | 0.784 | 0.892 | 0.770 | 0.980 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
95. | MligTC455_24302 | 149 | 3.11 | Mlig455_035632 | Neo: - Age: Up-Down-Up |
KCNQ5 | 3.424 | - | - | 0.901 | 0.795 | 0.740 | 0.988 | Mlig455_035632 {REF} {Length: 2263} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=124.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=122, Expect=1e-28]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [Score=121, Expect=2e-28]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=121, Expect=1e-28]; ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [Score=119, Expect=4e-28]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=175, Expect=1e-46]} {Celegans: WBGene00002235, kqt-3, KQT-3 potassium channel; Potassium channel, KvQLT family, [Score=110, Expect=1e-25]} {Smed: dd_Smed_v6_17359_0_2, dd_Smed_v6_17359_0_2, [Score=186, Expect=2e-52]} {RNA1509_34272} {RNA1310_3730.1} {RNA815_2787} |
96. | MligTC455_13963 | 31 | 0.64 | Mlig455_052027 | Neo: - Age: Down-Up-Down |
3.421 | 0.711 | - | 0.921 | 0.793 | - | 0.996 | Mlig455_052027 {REF} {Length: 1717} {RNA1509_48973} {RNA1310_34931} {RNA815_59614} | |
97. | MligTC455_51933 | 583 | 12.15 | Mlig455_024511 | Neo: - Age: logFC(26M/2M)=-0.429 Region-enriched R2: 2.089/0.00081 |
CBSL | 3.413 | 0.780 | 0.951 | 0.833 | - | - | 0.849 | Mlig455_024511 {REF} {Length: 1959} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=138.0]; CBS domain [PF00571.30, score=48.9]} {Human: ENSG00000274276, CBSL, cystathionine-beta-synthase like, [Score=463, Expect=3e-160]; ENSG00000160200, CBS, cystathionine-beta-synthase, [Score=463, Expect=3e-160]} {Mouse: ENSMUSG00000024039, Cbs, cystathionine beta-synthase, [Score=467, Expect=6e-162]} {Dmel: FBgn0031148, Cbs, centrosomin's beautiful sister, [Score=327, Expect=2e-107]} {Celegans: WBGene00013866, cbs-1, Cystathionine Beta-Synthase, [Score=264, Expect=2e-81]} {Smed: dd_Smed_v6_1585_0_1, dd_Smed_v6_1585_0_1, [Score=511, Expect=6e-180]} {RNA1509_36721} {RNA1310_10809} {RNA815_3797.1} |
98. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
3.409 | 0.703 | - | 0.910 | 0.827 | - | 0.969 | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
99. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 3.408 | 0.705 | - | 0.940 | 0.772 | - | 0.991 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
100. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
3.403 | 0.720 | - | 0.975 | 0.737 | - | 0.971 | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} |